The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity
Author(s) -
Min Li,
Andrea C. Mislak,
Yram Foli,
Esinam Agbosu,
Vivek Bose,
Shreya Bhandari,
Michał R. Szymański,
Christie K. Shumate,
Y. Whitney Yin,
Karen S. Anderson,
Elijah Paintsil
Publication year - 2016
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00976-16
Subject(s) - polymerase , mutant , microbiology and biotechnology , dna polymerase , mitochondrial dna , biology , mitochondrial toxicity , nucleotide , nucleotidyltransferase , wild type , dna , biochemistry , mitochondrion , rna , gene
We found a heterozygous C2857T mutation (R953C) in polymerase gamma (Pol-γ) in an HIV-infected patient with mitochondrial toxicity. The R953C Pol-γ mutant binding affinity for dCTP is 8-fold less than that of the wild type. The R953C mutant shows a 4-fold decrease in discrimination of analog nucleotides relative to the wild type. R953 is located on the "O-helix" that forms the substrate deoxynucleoside triphosphate (dNTP) binding site; the interactions of R953 with E1056 and Y986 may stabilize the O-helix and affect polymerase activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom